ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

0Q6H Hofseth Biocare Asa

2.00
0.00 (0.00%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hofseth Biocare Asa LSE:0Q6H London Ordinary Share NO0010598683 HOFSETH BIOCARE ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 218.51M -106.68M -0.2700 -7.41 790.16M

Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING

27/11/2023 10:05am

GlobeNewswire Inc.


Hofseth Biocare Asa (LSE:0Q6H)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Hofseth Biocare Asa Charts.
Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Reference is made to the mandatory notification of trade by Hofseth International AS announced on 27 November 2023.

As a result of the purchase of 435,207 shares in the Hofseth BioCare ASA (the "Company"), Hofseth International AS will surpass a holding of 15% of the outstanding shares and votes in the Company. Following the transaction, Hofseth International AS will hold 59,611,772 shares in the Company, corresponding to 15.09% of the total outstanding shares and votes in the Company.

Hofseth International AS is a company controlled by Roger Hofseth (through RH Industri AS and RH Investments AS). The transaction does not imply that Roger Hofseth and associated parties surpass a notifiable threshold. Following the transaction, Roger Hofseth and associated parties will hold 129,111,962 shares in the Company, corresponding to 32.68% of the total outstanding shares and votes in the Company.

This information is subject of the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.

1 Year Hofseth Biocare Asa Chart

1 Year Hofseth Biocare Asa Chart

1 Month Hofseth Biocare Asa Chart

1 Month Hofseth Biocare Asa Chart

Your Recent History

Delayed Upgrade Clock